Remicade® is a TNF-alpha inhibitor used to treat autoimmune and inflammatory conditions. Administered via IV, it reduces inflammation and prevents damage caused by overactive immune responses.
therapies we administer
Conditions Treated
- Rheumatoid Arthritis (RA)
- Psoriatic Arthritis (PsA)
- Crohn’s Disease
- Ulcerative Colitis
- Ankylosing Spondylitis
How It Works
Remicade® binds to tumor necrosis factor-alpha (TNF-α), a protein that promotes systemic inflammation. Blocking TNF helps alleviate disease symptoms and slow progression.
Infusion Schedule & Duration
- Induction Phase: At weeks 0, 2, and 6
- Maintenance Phase: Every 6–8 weeks
- Infusion Time: 2–3 hours
- Pre-meds: Often includes antihistamines or acetaminophen
What to Expect
- Vital signs monitored throughout the infusion
- Restful, quiet environment with access to amenities
- Continuous assessment by trained staff
Potential Side Effects
- Infusion reactions (chills, fever)
- Respiratory infections
- Headache or nausea
GET IN TOUCH
Referrals & Insurance
Requires a referral from a licensed physician. Prior authorization may be necessary.